APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fibromyalgia Therapeutics Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Fibromyalgia Therapeutics Drugs Industry Growth and Trends Forecast to 2032

31 December 2025110 pages

Choose your research edition.

Industry ResearchFibromyalgia Therapeutics Drugs Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Fibromyalgia Therapeutics Drugs Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Fibromyalgia Therapeutics Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fibromyalgia Therapeutics Drugs Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Fibromyalgia Therapeutics Drugs Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Fibromyalgia Therapeutics Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Fibromyalgia Therapeutics Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Fibromyalgia Therapeutics Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Fibromyalgia Therapeutics Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Fibromyalgia Therapeutics Drugs include Eli Lilly, Pfizer, Zynerba Pharmaceuticals, Tonix Pharmaceuticals Holding Corp. (TNXP), Theravance, Switch Biotech, Pierre Fabre Mdicament, Merck Sharp and Dohme and Meiji Seika, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Fibromyalgia Therapeutics Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Fibromyalgia Therapeutics Drugs market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Fibromyalgia Therapeutics Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Fibromyalgia Therapeutics Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Fibromyalgia Therapeutics Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Fibromyalgia Therapeutics Drugs Market by Company

Eli Lilly

Pfizer

Zynerba Pharmaceuticals

Tonix Pharmaceuticals Holding Corp. (TNXP)

Theravance

Switch Biotech

Pierre Fabre Mdicament

Merck Sharp and Dohme

Meiji Seika

Meda

Innovative Med Concepts

Forest Pharmaceuticals, Inc.

Daiichi Sankyo

Daiichi Sankyo

Boehringer Ingelheim GmbH

Actavis

Fibromyalgia Therapeutics Drugs Segment by Type

Cymbalta (Duloxetine)

Savella (Milnacipran)

Lyrica (Pregabalin)

Pancuronium

Others

Fibromyalgia Therapeutics Drugs Segment by Application

Hospital

Clinic

Others

Fibromyalgia Therapeutics Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fibromyalgia Therapeutics Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fibromyalgia Therapeutics Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fibromyalgia Therapeutics Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Fibromyalgia Therapeutics Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Fibromyalgia Therapeutics Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Cymbalta (Duloxetine) Table 2. Major Company of Savella (Milnacipran) Table 3. Major Company of Lyrica (Pregabalin) Table 4. Major Company of Pancuronium Table 5. Major Company of Others Table 6. Global Fibromyalgia Therapeutics Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Fibromyalgia Therapeutics Drugs Sales by Type (2021-2026) & (Kg) Table 8. Global Fibromyalgia Therapeutics Drugs Sales Market Share in Volume by Type (2021-2026) Table 9. Global Fibromyalgia Therapeutics Drugs Sales by Type (2021-2026) & (US$ Million) Table 10. Global Fibromyalgia Therapeutics Drugs Sales Market Share in Value by Type (2021-2026) Table 11. Global Fibromyalgia Therapeutics Drugs Price by Type (2021-2026) & (US$/g) Table 12. Global Fibromyalgia Therapeutics Drugs Sales by Type (2027-2032) & (Kg) Table 13. Global Fibromyalgia Therapeutics Drugs Sales Market Share in Volume by Type (2027-2032) Table 14. Global Fibromyalgia Therapeutics Drugs Sales by Type (2027-2032) & (US$ Million) Table 15. Global Fibromyalgia Therapeutics Drugs Sales Market Share in Value by Type (2027-2032) Table 16. Global Fibromyalgia Therapeutics Drugs Price by Type (2027-2032) & (US$/g) Table 17. North America Fibromyalgia Therapeutics Drugs Sales by Type (2021-2026) & (Kg) Table 18. North America Fibromyalgia Therapeutics Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Fibromyalgia Therapeutics Drugs Sales by Type (2021-2026) & (Kg) Table 20. Europe Fibromyalgia Therapeutics Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Fibromyalgia Therapeutics Drugs Sales by Type (2021-2026) & (Kg) Table 22. Asia-Pacific Fibromyalgia Therapeutics Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Fibromyalgia Therapeutics Drugs Sales by Type (2021-2026) & (Kg) Table 24. Latin America Fibromyalgia Therapeutics Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Type (2021-2026) & (Kg) Table 26. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Type (2021-2026) & (US$ Million) Table 27. Fibromyalgia Therapeutics Drugs Industry Trends Table 28. Fibromyalgia Therapeutics Drugs Industry Drivers Table 29. Fibromyalgia Therapeutics Drugs Industry Opportunities and Challenges Table 30. Fibromyalgia Therapeutics Drugs Industry Restraints Table 31. Global Fibromyalgia Therapeutics Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Company (2021-2026) Table 33. Global Fibromyalgia Therapeutics Drugs Sales by Company (2021-2026) & (Kg) Table 34. Global Fibromyalgia Therapeutics Drugs Sales Share by Company (2021-2026) Table 35. Global Fibromyalgia Therapeutics Drugs Market Price by Company (2021-2026) & (US$/g) Table 36. Global Fibromyalgia Therapeutics Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Fibromyalgia Therapeutics Drugs Major Company Production Sites and Headquarters Table 38. Global Fibromyalgia Therapeutics Drugs Company, Product Type & Application Table 39. Global Fibromyalgia Therapeutics Drugs Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Fibromyalgia Therapeutics Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Fibromyalgia Therapeutics Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Fibromyalgia Therapeutics Drugs Sales by Region (2021-2026) & (Kg) Table 44. Global Fibromyalgia Therapeutics Drugs Sales Market Share in Volume by Region (2021-2026) Table 45. Global Fibromyalgia Therapeutics Drugs Sales by Region (2021-2026) & (US$ Million) Table 46. Global Fibromyalgia Therapeutics Drugs Sales Market Share in Value by Region (2021-2026) Table 47. Global Fibromyalgia Therapeutics Drugs Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 48. Global Fibromyalgia Therapeutics Drugs Sales by Region (2027-2032) & (Kg) Table 49. Global Fibromyalgia Therapeutics Drugs Sales Market Share in Volume by Region (2027-2032) Table 50. Global Fibromyalgia Therapeutics Drugs Sales by Region (2027-2032) & (US$ Million) Table 51. Global Fibromyalgia Therapeutics Drugs Sales Market Share in Value by Region (2027-2032) Table 52. Global Fibromyalgia Therapeutics Drugs Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2027-2032) Table 53. Global Fibromyalgia Therapeutics Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Fibromyalgia Therapeutics Drugs Sales by Application (2021-2026) & (Kg) Table 55. Global Fibromyalgia Therapeutics Drugs Sales Market Share in Volume by Application (2021-2026) Table 56. Global Fibromyalgia Therapeutics Drugs Sales by Application (2021-2026) & (US$ Million) Table 57. Global Fibromyalgia Therapeutics Drugs Sales Market Share in Value by Application (2021-2026) Table 58. Global Fibromyalgia Therapeutics Drugs Price by Application (2021-2026) & (US$/g) Table 59. Global Fibromyalgia Therapeutics Drugs Sales by Application (2027-2032) & (Kg) Table 60. Global Fibromyalgia Therapeutics Drugs Sales Market Share in Volume by Application (2027-2032) Table 61. Global Fibromyalgia Therapeutics Drugs Sales by Application (2027-2032) & (US$ Million) Table 62. Global Fibromyalgia Therapeutics Drugs Sales Market Share in Value by Application (2027-2032) Table 63. Global Fibromyalgia Therapeutics Drugs Price by Application (2027-2032) & (US$/g) Table 64. North America Fibromyalgia Therapeutics Drugs Sales by Application (2021-2026) & (Kg) Table 65. North America Fibromyalgia Therapeutics Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Fibromyalgia Therapeutics Drugs Sales by Application (2021-2026) & (Kg) Table 67. Europe Fibromyalgia Therapeutics Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Fibromyalgia Therapeutics Drugs Sales by Application (2021-2026) & (Kg) Table 69. Asia-Pacific Fibromyalgia Therapeutics Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Fibromyalgia Therapeutics Drugs Sales by Application (2021-2026) & (Kg) Table 71. Latin America Fibromyalgia Therapeutics Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Application (2021-2026) & (Kg) Table 73. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Application (2021-2026) & (US$ Million) Table 74. Eli Lilly Company Information Table 75. Eli Lilly Business Overview Table 76. Eli Lilly Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 77. Eli Lilly Fibromyalgia Therapeutics Drugs Product Portfolio Table 78. Eli Lilly Recent Development Table 79. Pfizer Company Information Table 80. Pfizer Business Overview Table 81. Pfizer Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 82. Pfizer Fibromyalgia Therapeutics Drugs Product Portfolio Table 83. Pfizer Recent Development Table 84. Zynerba Pharmaceuticals Company Information Table 85. Zynerba Pharmaceuticals Business Overview Table 86. Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 87. Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Product Portfolio Table 88. Zynerba Pharmaceuticals Recent Development Table 89. Tonix Pharmaceuticals Holding Corp. (TNXP) Company Information Table 90. Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview Table 91. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 92. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Product Portfolio Table 93. Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development Table 94. Theravance Company Information Table 95. Theravance Business Overview Table 96. Theravance Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 97. Theravance Fibromyalgia Therapeutics Drugs Product Portfolio Table 98. Theravance Recent Development Table 99. Switch Biotech Company Information Table 100. Switch Biotech Business Overview Table 101. Switch Biotech Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 102. Switch Biotech Fibromyalgia Therapeutics Drugs Product Portfolio Table 103. Switch Biotech Recent Development Table 104. Pierre Fabre Mdicament Company Information Table 105. Pierre Fabre Mdicament Business Overview Table 106. Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 107. Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Product Portfolio Table 108. Pierre Fabre Mdicament Recent Development Table 109. Merck Sharp and Dohme Company Information Table 110. Merck Sharp and Dohme Business Overview Table 111. Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 112. Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Product Portfolio Table 113. Merck Sharp and Dohme Recent Development Table 114. Meiji Seika Company Information Table 115. Meiji Seika Business Overview Table 116. Meiji Seika Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 117. Meiji Seika Fibromyalgia Therapeutics Drugs Product Portfolio Table 118. Meiji Seika Recent Development Table 119. Meda Company Information Table 120. Meda Business Overview Table 121. Meda Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 122. Meda Fibromyalgia Therapeutics Drugs Product Portfolio Table 123. Meda Recent Development Table 124. Innovative Med Concepts Company Information Table 125. Innovative Med Concepts Business Overview Table 126. Innovative Med Concepts Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 127. Innovative Med Concepts Fibromyalgia Therapeutics Drugs Product Portfolio Table 128. Innovative Med Concepts Recent Development Table 129. Forest Pharmaceuticals, Inc. Company Information Table 130. Forest Pharmaceuticals, Inc. Business Overview Table 131. Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 132. Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Product Portfolio Table 133. Forest Pharmaceuticals, Inc. Recent Development Table 134. Daiichi Sankyo Company Information Table 135. Daiichi Sankyo Business Overview Table 136. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 137. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Product Portfolio Table 138. Daiichi Sankyo Recent Development Table 139. Daiichi Sankyo Company Information Table 140. Daiichi Sankyo Business Overview Table 141. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 142. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Product Portfolio Table 143. Daiichi Sankyo Recent Development Table 144. Boehringer Ingelheim GmbH Company Information Table 145. Boehringer Ingelheim GmbH Business Overview Table 146. Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 147. Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Product Portfolio Table 148. Boehringer Ingelheim GmbH Recent Development Table 149. Actavis Company Information Table 150. Actavis Business Overview Table 151. Actavis Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 152. Actavis Fibromyalgia Therapeutics Drugs Product Portfolio Table 153. Actavis Recent Development Table 154. North America Fibromyalgia Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 155. North America Fibromyalgia Therapeutics Drugs Sales by Country (2021-2026) & (Kg) Table 156. North America Fibromyalgia Therapeutics Drugs Sales Market Share by Country (2021-2026) Table 157. North America Fibromyalgia Therapeutics Drugs Sales Forecast by Country (2027-2032) & (Kg) Table 158. North America Fibromyalgia Therapeutics Drugs Sales Market Share Forecast by Country (2027-2032) Table 159. North America Fibromyalgia Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. North America Fibromyalgia Therapeutics Drugs Market Size by Country (2021-2026) & (US$ Million) Table 161. North America Fibromyalgia Therapeutics Drugs Market Share by Country (2021-2026) Table 162. North America Fibromyalgia Therapeutics Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. North America Fibromyalgia Therapeutics Drugs Market Share Forecast by Country (2027-2032) Table 164. Europe Fibromyalgia Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 165. Europe Fibromyalgia Therapeutics Drugs Sales by Country (2021-2026) & (Kg) Table 166. Europe Fibromyalgia Therapeutics Drugs Sales Market Share by Country (2021-2026) Table 167. Europe Fibromyalgia Therapeutics Drugs Sales Forecast by Country (2027-2032) & (Kg) Table 168. Europe Fibromyalgia Therapeutics Drugs Sales Market Share Forecast by Country (2027-2032) Table 169. Europe Fibromyalgia Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Europe Fibromyalgia Therapeutics Drugs Market Size by Country (2021-2026) & (US$ Million) Table 171. Europe Fibromyalgia Therapeutics Drugs Market Share by Country (2021-2026) Table 172. Europe Fibromyalgia Therapeutics Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Europe Fibromyalgia Therapeutics Drugs Market Share Forecast by Country (2027-2032) Table 174. Asia-Pacific Fibromyalgia Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 175. Asia-Pacific Fibromyalgia Therapeutics Drugs Sales by Country (2021-2026) & (Kg) Table 176. Asia-Pacific Fibromyalgia Therapeutics Drugs Sales Market Share by Country (2021-2026) Table 177. Asia-Pacific Fibromyalgia Therapeutics Drugs Sales Forecast by Country (2027-2032) & (Kg) Table 178. Asia-Pacific Fibromyalgia Therapeutics Drugs Sales Market Share Forecast by Country (2027-2032) Table 179. Asia-Pacific Fibromyalgia Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 180. Asia-Pacific Fibromyalgia Therapeutics Drugs Market Size by Country (2021-2026) & (US$ Million) Table 181. Asia-Pacific Fibromyalgia Therapeutics Drugs Market Share by Country (2021-2026) Table 182. Asia-Pacific Fibromyalgia Therapeutics Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 183. Asia-Pacific Fibromyalgia Therapeutics Drugs Market Share Forecast by Country (2027-2032) Table 184. Latin America Fibromyalgia Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 185. Latin America Fibromyalgia Therapeutics Drugs Sales by Country (2021-2026) & (Kg) Table 186. Latin America Fibromyalgia Therapeutics Drugs Sales Market Share by Country (2021-2026) Table 187. Latin America Fibromyalgia Therapeutics Drugs Sales Forecast by Country (2027-2032) & (Kg) Table 188. Latin America Fibromyalgia Therapeutics Drugs Sales Market Share Forecast by Country (2027-2032) Table 189. Latin America Fibromyalgia Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 190. Latin America Fibromyalgia Therapeutics Drugs Market Size by Country (2021-2026) & (US$ Million) Table 191. Latin America Fibromyalgia Therapeutics Drugs Market Share by Country (2021-2026) Table 192. Latin America Fibromyalgia Therapeutics Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 193. Latin America Fibromyalgia Therapeutics Drugs Market Share Forecast by Country (2027-2032) Table 194. Middle East and Africa Fibromyalgia Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 195. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Country (2021-2026) & (Kg) Table 196. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales Market Share by Country (2021-2026) Table 197. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales Forecast by Country (2027-2032) & (Kg) Table 198. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales Market Share Forecast by Country (2027-2032) Table 199. Middle East and Africa Fibromyalgia Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 200. Middle East and Africa Fibromyalgia Therapeutics Drugs Market Size by Country (2021-2026) & (US$ Million) Table 201. Middle East and Africa Fibromyalgia Therapeutics Drugs Market Share by Country (2021-2026) Table 202. Middle East and Africa Fibromyalgia Therapeutics Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 203. Middle East and Africa Fibromyalgia Therapeutics Drugs Market Share Forecast by Country (2027-2032) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. Fibromyalgia Therapeutics Drugs Distributors List Table 207. Fibromyalgia Therapeutics Drugs Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. Fibromyalgia Therapeutics Drugs Image Figure 2. Global Fibromyalgia Therapeutics Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fibromyalgia Therapeutics Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Fibromyalgia Therapeutics Drugs Sales (2021-2032) & (Kg) Figure 5. Cymbalta (Duloxetine) Image Figure 6. Global Cymbalta (Duloxetine) Sales YoY Growth (2021-2032) & (Kg) Figure 7. Savella (Milnacipran) Image Figure 8. Global Savella (Milnacipran) Sales YoY Growth (2021-2032) & (Kg) Figure 9. Lyrica (Pregabalin) Image Figure 10. Global Lyrica (Pregabalin) Sales YoY Growth (2021-2032) & (Kg) Figure 11. Pancuronium Image Figure 12. Global Pancuronium Sales YoY Growth (2021-2032) & (Kg) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (Kg) Figure 15. Global Fibromyalgia Therapeutics Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Fibromyalgia Therapeutics Drugs Market Share by Type 2025 VS 2032 Figure 17. North America Fibromyalgia Therapeutics Drugs Sales Market Share in Volume by Type in 2025 Figure 18. North America Fibromyalgia Therapeutics Drugs Sales Market Share in Value by Type in 2025 Figure 19. Europe Fibromyalgia Therapeutics Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Europe Fibromyalgia Therapeutics Drugs Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Fibromyalgia Therapeutics Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Fibromyalgia Therapeutics Drugs Sales Market Share in Value by Type in 2025 Figure 23. Latin America Fibromyalgia Therapeutics Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Fibromyalgia Therapeutics Drugs Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Fibromyalgia Therapeutics Drugs Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (Kg) Figure 31. Clinic Image Figure 32. Global Clinic Sales YoY Growth (2021-2032) & (Kg) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (Kg) Figure 35. Global Fibromyalgia Therapeutics Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Fibromyalgia Therapeutics Drugs Market Share by Application 2025 VS 2032 Figure 37. North America Fibromyalgia Therapeutics Drugs Sales Market Share in Volume by Application in 2025 Figure 38. North America Fibromyalgia Therapeutics Drugs Sales Market Share in Value by Application in 2025 Figure 39. Europe Fibromyalgia Therapeutics Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Europe Fibromyalgia Therapeutics Drugs Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Fibromyalgia Therapeutics Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Fibromyalgia Therapeutics Drugs Sales Market Share in Value by Application in 2025 Figure 43. Latin America Fibromyalgia Therapeutics Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Fibromyalgia Therapeutics Drugs Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales Market Share in Value by Application in 2025 Figure 47. North America Fibromyalgia Therapeutics Drugs Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 48. North America Fibromyalgia Therapeutics Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Fibromyalgia Therapeutics Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Fibromyalgia Therapeutics Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Fibromyalgia Therapeutics Drugs Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 52. Europe Fibromyalgia Therapeutics Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Fibromyalgia Therapeutics Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Fibromyalgia Therapeutics Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Fibromyalgia Therapeutics Drugs Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 56. Asia-Pacific Fibromyalgia Therapeutics Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Fibromyalgia Therapeutics Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Fibromyalgia Therapeutics Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Fibromyalgia Therapeutics Drugs Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 60. Latin America Fibromyalgia Therapeutics Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Fibromyalgia Therapeutics Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Fibromyalgia Therapeutics Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 64. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Fibromyalgia Therapeutics Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Fibromyalgia Therapeutics Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Fibromyalgia Therapeutics Drugs Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Fibromyalgia Therapeutics Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Cymbalta (Duloxetine)
  • Savella (Milnacipran)
  • Lyrica (Pregabalin)
  • Pancuronium
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Eli Lilly
  • Pfizer
  • Zynerba Pharmaceuticals
  • Tonix Pharmaceuticals Holding Corp. (TNXP)
  • Theravance
  • Switch Biotech
  • Pierre Fabre Mdicament
  • Merck Sharp and Dohme
  • Meiji Seika
  • Meda
  • Innovative Med Concepts
  • Forest Pharmaceuticals, Inc.
  • Daiichi Sankyo
  • Daiichi Sankyo
  • Boehringer Ingelheim GmbH
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Fibromyalgia Therapeutics Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Fibromyalgia Therapeutics Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Fibromyalgia Therapeutics Drugs Market by Type
  6. 1.3.1 Cymbalta (Duloxetine)
  7. 1.3.2 Savella (Milnacipran)
  8. 1.3.3 Lyrica (Pregabalin)
  9. 1.3.4 Pancuronium
  10. 1.3.5 Others
  11. 1.4 Global Fibromyalgia Therapeutics Drugs Market Size by Type
  12. 1.4.1 Global Fibromyalgia Therapeutics Drugs Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Fibromyalgia Therapeutics Drugs Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Fibromyalgia Therapeutics Drugs Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Fibromyalgia Therapeutics Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Fibromyalgia Therapeutics Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Fibromyalgia Therapeutics Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Fibromyalgia Therapeutics Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Fibromyalgia Therapeutics Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Fibromyalgia Therapeutics Drugs Industry Trends
  2. 2.2 Fibromyalgia Therapeutics Drugs Industry Drivers
  3. 2.3 Fibromyalgia Therapeutics Drugs Industry Opportunities and Challenges
  4. 2.4 Fibromyalgia Therapeutics Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Fibromyalgia Therapeutics Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Fibromyalgia Therapeutics Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Fibromyalgia Therapeutics Drugs Price (2021-2026)
  4. 3.4 Global Fibromyalgia Therapeutics Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Fibromyalgia Therapeutics Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Fibromyalgia Therapeutics Drugs Company, Product Type & Application
  7. 3.7 Global Fibromyalgia Therapeutics Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Fibromyalgia Therapeutics Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Fibromyalgia Therapeutics Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Fibromyalgia Therapeutics Drugs Tier 1, Tier 2, and Tier 3
4 Fibromyalgia Therapeutics Drugs Regional Status and Outlook
  1. 4.1 Global Fibromyalgia Therapeutics Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Fibromyalgia Therapeutics Drugs Historic Market Size by Region
  3. 4.2.1 Global Fibromyalgia Therapeutics Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Fibromyalgia Therapeutics Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Fibromyalgia Therapeutics Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Fibromyalgia Therapeutics Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Fibromyalgia Therapeutics Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Fibromyalgia Therapeutics Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Fibromyalgia Therapeutics Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Fibromyalgia Therapeutics Drugs by Application
  1. 5.1 Fibromyalgia Therapeutics Drugs Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Fibromyalgia Therapeutics Drugs Market Size by Application
  6. 5.2.1 Global Fibromyalgia Therapeutics Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Fibromyalgia Therapeutics Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Fibromyalgia Therapeutics Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Fibromyalgia Therapeutics Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Fibromyalgia Therapeutics Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Fibromyalgia Therapeutics Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Fibromyalgia Therapeutics Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Fibromyalgia Therapeutics Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Eli Lilly
  2. 6.1.1 Eli Lilly Company Information
  3. 6.1.2 Eli Lilly Business Overview
  4. 6.1.3 Eli Lilly Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Eli Lilly Fibromyalgia Therapeutics Drugs Product Portfolio
  6. 6.1.5 Eli Lilly Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Fibromyalgia Therapeutics Drugs Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 Zynerba Pharmaceuticals
  14. 6.3.1 Zynerba Pharmaceuticals Company Information
  15. 6.3.2 Zynerba Pharmaceuticals Business Overview
  16. 6.3.3 Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Product Portfolio
  18. 6.3.5 Zynerba Pharmaceuticals Recent Developments
  19. 6.4 Tonix Pharmaceuticals Holding Corp. (TNXP)
  20. 6.4.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Company Information
  21. 6.4.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview
  22. 6.4.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Product Portfolio
  24. 6.4.5 Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Developments
  25. 6.5 Theravance
  26. 6.5.1 Theravance Company Information
  27. 6.5.2 Theravance Business Overview
  28. 6.5.3 Theravance Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Theravance Fibromyalgia Therapeutics Drugs Product Portfolio
  30. 6.5.5 Theravance Recent Developments
  31. 6.6 Switch Biotech
  32. 6.6.1 Switch Biotech Company Information
  33. 6.6.2 Switch Biotech Business Overview
  34. 6.6.3 Switch Biotech Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Switch Biotech Fibromyalgia Therapeutics Drugs Product Portfolio
  36. 6.6.5 Switch Biotech Recent Developments
  37. 6.7 Pierre Fabre Mdicament
  38. 6.7.1 Pierre Fabre Mdicament Company Information
  39. 6.7.2 Pierre Fabre Mdicament Business Overview
  40. 6.7.3 Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Product Portfolio
  42. 6.7.5 Pierre Fabre Mdicament Recent Developments
  43. 6.8 Merck Sharp and Dohme
  44. 6.8.1 Merck Sharp and Dohme Company Information
  45. 6.8.2 Merck Sharp and Dohme Business Overview
  46. 6.8.3 Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Product Portfolio
  48. 6.8.5 Merck Sharp and Dohme Recent Developments
  49. 6.9 Meiji Seika
  50. 6.9.1 Meiji Seika Company Information
  51. 6.9.2 Meiji Seika Business Overview
  52. 6.9.3 Meiji Seika Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Meiji Seika Fibromyalgia Therapeutics Drugs Product Portfolio
  54. 6.9.5 Meiji Seika Recent Developments
  55. 6.10 Meda
  56. 6.10.1 Meda Company Information
  57. 6.10.2 Meda Business Overview
  58. 6.10.3 Meda Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Meda Fibromyalgia Therapeutics Drugs Product Portfolio
  60. 6.10.5 Meda Recent Developments
  61. 6.11 Innovative Med Concepts
  62. 6.11.1 Innovative Med Concepts Company Information
  63. 6.11.2 Innovative Med Concepts Business Overview
  64. 6.11.3 Innovative Med Concepts Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Innovative Med Concepts Fibromyalgia Therapeutics Drugs Product Portfolio
  66. 6.11.5 Innovative Med Concepts Recent Developments
  67. 6.12 Forest Pharmaceuticals, Inc.
  68. 6.12.1 Forest Pharmaceuticals, Inc. Company Information
  69. 6.12.2 Forest Pharmaceuticals, Inc. Business Overview
  70. 6.12.3 Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Product Portfolio
  72. 6.12.5 Forest Pharmaceuticals, Inc. Recent Developments
  73. 6.13 Daiichi Sankyo
  74. 6.13.1 Daiichi Sankyo Company Information
  75. 6.13.2 Daiichi Sankyo Business Overview
  76. 6.13.3 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Product Portfolio
  78. 6.13.5 Daiichi Sankyo Recent Developments
  79. 6.14 Daiichi Sankyo
  80. 6.14.1 Daiichi Sankyo Company Information
  81. 6.14.2 Daiichi Sankyo Business Overview
  82. 6.14.3 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Product Portfolio
  84. 6.14.5 Daiichi Sankyo Recent Developments
  85. 6.15 Boehringer Ingelheim GmbH
  86. 6.15.1 Boehringer Ingelheim GmbH Company Information
  87. 6.15.2 Boehringer Ingelheim GmbH Business Overview
  88. 6.15.3 Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Product Portfolio
  90. 6.15.5 Boehringer Ingelheim GmbH Recent Developments
  91. 6.16 Actavis
  92. 6.16.1 Actavis Company Information
  93. 6.16.2 Actavis Business Overview
  94. 6.16.3 Actavis Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Actavis Fibromyalgia Therapeutics Drugs Product Portfolio
  96. 6.16.5 Actavis Recent Developments
7 North America by Country
  1. 7.1 North America Fibromyalgia Therapeutics Drugs Sales by Country
  2. 7.1.1 North America Fibromyalgia Therapeutics Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Fibromyalgia Therapeutics Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Fibromyalgia Therapeutics Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Fibromyalgia Therapeutics Drugs Market Size by Country
  6. 7.2.1 North America Fibromyalgia Therapeutics Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Fibromyalgia Therapeutics Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Fibromyalgia Therapeutics Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Fibromyalgia Therapeutics Drugs Sales by Country
  2. 8.1.1 Europe Fibromyalgia Therapeutics Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Fibromyalgia Therapeutics Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Fibromyalgia Therapeutics Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Fibromyalgia Therapeutics Drugs Market Size by Country
  6. 8.2.1 Europe Fibromyalgia Therapeutics Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Fibromyalgia Therapeutics Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Fibromyalgia Therapeutics Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Fibromyalgia Therapeutics Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Fibromyalgia Therapeutics Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Fibromyalgia Therapeutics Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Fibromyalgia Therapeutics Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Fibromyalgia Therapeutics Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Fibromyalgia Therapeutics Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Fibromyalgia Therapeutics Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Fibromyalgia Therapeutics Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Fibromyalgia Therapeutics Drugs Sales by Country
  2. 10.1.1 South America Fibromyalgia Therapeutics Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Fibromyalgia Therapeutics Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Fibromyalgia Therapeutics Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Fibromyalgia Therapeutics Drugs Market Size by Country
  6. 10.2.1 South America Fibromyalgia Therapeutics Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Fibromyalgia Therapeutics Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Fibromyalgia Therapeutics Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Fibromyalgia Therapeutics Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Fibromyalgia Therapeutics Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Fibromyalgia Therapeutics Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Fibromyalgia Therapeutics Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Fibromyalgia Therapeutics Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Fibromyalgia Therapeutics Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Fibromyalgia Therapeutics Drugs Value Chain Analysis
  2. 12.1.1 Fibromyalgia Therapeutics Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Fibromyalgia Therapeutics Drugs Production Mode & Process
  7. 12.2 Fibromyalgia Therapeutics Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Fibromyalgia Therapeutics Drugs Distributors
  10. 12.2.3 Fibromyalgia Therapeutics Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst